Analyst consensus rating
HCW Biologics Analyst Rating: none
Direct answer
HCW Biologics's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $30.00.
Forecast evidence checked September 18, 2026.
Get free HCW Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.06
- Average price target
- $30.00
- High price target
- $30.00
- Low price target
- $30.00
- Low target gap
- +1,356.3%
- Target upside
- +1,356.3%
- High target gap
- +1,356.3%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HCW Biologics?
HCW Biologics has a verified none consensus. The same dataset has an average price target of $30.00.
How far are HCW Biologics's low and high targets from the recorded price?
The low target implies +1,356.3%, while the high target implies +1,356.3%.
How many analysts are included in HCW Biologics's consensus?
The verified consensus includes 1 analysts.
How is HCW Biologics's target upside or downside calculated?
The average target of $30.00 is divided by the recorded price of $2.06, then one is subtracted to produce +1,356.3%. This does not guarantee a future return.
When was HCW Biologics's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.